Biotechnology New GBT Multinational Survey Shines a Needed Light on the Misunderstood Realities, Unseen Burden and Care Challenges of Sickle Cell Disease June 13, 2022
Biotechnology BridgeBio Pharma Shares Positive Phase 2b Data and Announces Pivotal Study Design for Phase 3 Trial of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) June 13, 2022
Biotechnology Biohaven Presents New Migraine Data at 64th Annual Scientific Meeting of the American Headache Society, including First of Its Kind Study for Nurtec® ODT (rimegepant), and Complete Phase 3 Data for Zavegepant Nasal Spray June 13, 2022
Biotechnology CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease June 13, 2022
Biotechnology ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AXSM June 12, 2022
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Blueprint Medicines Corporation – BPMC June 11, 2022
Biotechnology CRISPR Therapeutics Presents Positive Results from its Phase 1 COBALT(TM)-LYM Trial of CTX130(TM) in Relapsed or Refractory T Cell Malignancies at the 2022 European Hematology Association (EHA) Congress June 11, 2022
Biotechnology The Gross Law Firm Announces Class Actions on Behalf of Shareholders of XRAY, AXSM and IONQ June 10, 2022
Search
biotech stock market
